286 related articles for article (PubMed ID: 23370378)
1. Dendritic cell vaccination in autoimmune disease.
Gross CC; Wiendl H
Curr Opin Rheumatol; 2013 Mar; 25(2):268-74. PubMed ID: 23370378
[TBL] [Abstract][Full Text] [Related]
2. Tolerogenic dendritic cells for reprogramming of lymphocyte responses in autoimmune diseases.
García-González P; Ubilla-Olguín G; Catalán D; Schinnerling K; Aguillón JC
Autoimmun Rev; 2016 Nov; 15(11):1071-1080. PubMed ID: 27485011
[TBL] [Abstract][Full Text] [Related]
3. Tolerogenic dendritic cell vaccines to treat autoimmune diseases: can the unattainable dream turn into reality?
Van Brussel I; Lee WP; Rombouts M; Nuyts AH; Heylen M; De Winter BY; Cools N; Schrijvers DM
Autoimmun Rev; 2014 Feb; 13(2):138-50. PubMed ID: 24120737
[TBL] [Abstract][Full Text] [Related]
4. Does our current understanding of the molecular basis of immune tolerance predict new therapies for autoimmune disease?
Tarner IH; Fathman CG
Nat Clin Pract Rheumatol; 2006 Sep; 2(9):491-9. PubMed ID: 16951704
[TBL] [Abstract][Full Text] [Related]
5. Skewing dendritic cell differentiation towards a tolerogenic state for recovery of tolerance in rheumatoid arthritis.
Schinnerling K; Soto L; García-González P; Catalán D; Aguillón JC
Autoimmun Rev; 2015 Jun; 14(6):517-27. PubMed ID: 25633325
[TBL] [Abstract][Full Text] [Related]
6. Oral tolerance: elucidation of mechanisms and application to treatment of autoimmune diseases.
Fowler E; Weiner HL
Biopolymers; 1997; 43(4):323-35. PubMed ID: 9316395
[TBL] [Abstract][Full Text] [Related]
7. Targeting of tolerogenic dendritic cells towards heat-shock proteins: a novel therapeutic strategy for autoimmune diseases?
Jansen MAA; Spiering R; Broere F; van Laar JM; Isaacs JD; van Eden W; Hilkens CMU
Immunology; 2018 Jan; 153(1):51-59. PubMed ID: 28804903
[TBL] [Abstract][Full Text] [Related]
8. Generation, Characteristics and Clinical Trials of Ex Vivo Generated Tolerogenic Dendritic Cells.
Kim SH; Jung HH; Lee CK
Yonsei Med J; 2018 Sep; 59(7):807-815. PubMed ID: 30091313
[TBL] [Abstract][Full Text] [Related]
9. Tolerogenic dendritic cells for autoimmune disease and transplantation.
Thomson AW; Robbins PD
Ann Rheum Dis; 2008 Dec; 67 Suppl 3():iii90-6. PubMed ID: 19022823
[TBL] [Abstract][Full Text] [Related]
10. Extrathymic generation of regulatory T cells--chances and challenges for prevention of autoimmune disease.
Daniel C; von Boehmer H
Adv Immunol; 2011; 112():177-213. PubMed ID: 22118409
[TBL] [Abstract][Full Text] [Related]
11. Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens.
Weiner HL; Friedman A; Miller A; Khoury SJ; al-Sabbagh A; Santos L; Sayegh M; Nussenblatt RB; Trentham DE; Hafler DA
Annu Rev Immunol; 1994; 12():809-37. PubMed ID: 8011298
[TBL] [Abstract][Full Text] [Related]
12. Dendritic cells as targets or therapeutics in rheumatic autoimmune disease.
Thomas R
Curr Opin Rheumatol; 2014 Mar; 26(2):211-8. PubMed ID: 24389864
[TBL] [Abstract][Full Text] [Related]
13. Antigen-specific tolerogenic dendritic cells ameliorate the severity of murine collagen-induced arthritis.
Ning B; Wei J; Zhang A; Gong W; Fu J; Jia T; Yang SY
PLoS One; 2015; 10(6):e0131152. PubMed ID: 26107250
[TBL] [Abstract][Full Text] [Related]
14. Induction of tolerogenic dendritic cells by NF-κB blockade and Fcγ receptor modulation.
Carreño LJ; Riedel CA; Kalergis AM
Methods Mol Biol; 2011; 677():339-53. PubMed ID: 20941620
[TBL] [Abstract][Full Text] [Related]
15. Tolerogenic dendritic cells: the ins and outs of outcome.
Xiao BG; Huang YM; Link H
J Immunother; 2006; 29(5):465-71. PubMed ID: 16971802
[TBL] [Abstract][Full Text] [Related]
16. IL-10 gene modified dendritic cells induced antigen-specific tolerance in experimental autoimmune myocarditis.
Yang S; Li W; Liu W; Gao C; Zhou B; Li S; Li Y; Kong Y
Clin Immunol; 2006 Oct; 121(1):63-73. PubMed ID: 16904381
[TBL] [Abstract][Full Text] [Related]
17. Regulatory T cells and tolerogenic dendritic cells: from basic biology to clinical applications.
Rutella S; Lemoli RM
Immunol Lett; 2004 Jun; 94(1-2):11-26. PubMed ID: 15234530
[TBL] [Abstract][Full Text] [Related]
18. Role of dendritic cells in the initiation, progress and modulation of systemic autoimmune diseases.
Mackern-Oberti JP; Llanos C; Vega F; Salazar-Onfray F; Riedel CA; Bueno SM; Kalergis AM
Autoimmun Rev; 2015 Feb; 14(2):127-39. PubMed ID: 25449681
[TBL] [Abstract][Full Text] [Related]
19. Oral tolerance: therapeutic implications for autoimmune diseases.
Faria AM; Weiner HL
Clin Dev Immunol; 2006; 13(2-4):143-57. PubMed ID: 17162357
[TBL] [Abstract][Full Text] [Related]
20. Oral tolerance in the control of experimental models of autoimmune disease.
Staines NA; Harper N
Z Rheumatol; 1995; 54(3):145-54. PubMed ID: 7660685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
